In 2023, the import of streptomycins to France stood at approximately 4.35 million USD. The forecasted data indicates a gradual increase from 2024 to 2028, with values rising each year by a consistent margin. From 2024, starting at 4.4119 million USD, the expected year-on-year growth illustrates approximately 1.22% annually. Over the five-year forecasted period, the compound annual growth rate (CAGR) equates to around 1.15%, showing moderate but steady growth in imports.
Future trends to watch for include:
- Potential shifts in global production affecting supply and pricing.
- Regulatory changes in pharmaceutical imports.
- Emerging competition from alternative antibiotic treatments.
- The impact of healthcare policy reforms on import demands.
